What is Adaptive Biotechnologies's revenue?

Adaptive Biotechnologies (ADPT) reported revenue of $70.87M in Q1 2026.

How has Adaptive Biotechnologies's revenue changed year-over-year?

Adaptive Biotechnologies's revenue increased by 35.1% year-over-year, from $52.44M to $70.87M.

What is the long-term trend for Adaptive Biotechnologies's revenue?

Over 4 years (2021 to 2025), Adaptive Biotechnologies's revenue has grown at a 15.7% compound annual growth rate (CAGR), from $154.34M to $276.98M.

Adaptive Biotechnologies ADPT Revenue

Revenue at other companies

HTF

Heartflow, Inc. Common StockHTFL

$52.59M+41.3%

Cal-Maine FoodsCALM

$666.95M-53.0%

DJT

Trump Media & Technology GroupDJT

$871.2K+6.1%

ADMA BiologicsADMA

$114.49M-0.3%

Minerals TechnologiesMTX

$546.9M+11.2%

PhotronicsPLAB

$209.94M-0.5%

Other financials

Income statement

See full

Revenue$70.9M+35.1%

Gross profit$52.2M+47.1%

Operating income-$19.2M+35.1%

Net income-$20.0M+32.9%

EPS (diluted)-$0.13+35.0%

Balance sheet

See full

Cash & equivalents$77.6M+53.2%

Total debt$208.2M-5.6%

Total equity$216.3M+13.6%

Total assets$505.9M-1.0%

Cash flow

See full

Operating cash flow-$9.5M+66.5%

CapEx$796.0K-36.8%

Free cash flow-$10.3M+65.3%

Valuation

See full

Market cap$2.76B+93.6%

Enterprise value$2.89B+78.0%

P/S9.3×+1.8×

Profitability

See full

Gross margin75.3%+12.7pp

Operating margin-15.8%-7.0pp

Net margin-16.8%-7.3pp

FCF margin-10.5%-4.6pp

Returns & leverage

See full

Return on equity-24.4%-9.2pp

Debt / equity1×-0.2×

Current ratio3.4×+0.4×

Where this comes from

Reported directly by Adaptive Biotechnologies in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Adaptive Biotechnologies’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Adaptive Biotechnologies's revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Adaptive Biotechnologies's revenue?: Adaptive Biotechnologies (ADPT) reported revenue of $70.87M in Q1 2026.
How has Adaptive Biotechnologies's revenue changed year-over-year?: Adaptive Biotechnologies's revenue increased by 35.1% year-over-year, from $52.44M to $70.87M.
What is the long-term trend for Adaptive Biotechnologies's revenue?: Over 4 years (2021 to 2025), Adaptive Biotechnologies's revenue has grown at a 15.7% compound annual growth rate (CAGR), from $154.34M to $276.98M.